FDA Approves Fruquintinib for Metastatic Colorectal Cancer FDA Approves Fruquintinib for Metastatic Colorectal Cancer

This marks the first approval for the oral anti-VEGFR tyrosine kinase inhibitor.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news